Reader Response: Long-term Neurologic Safety in Patients With B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy. . Neurology 2023 May 3:10.1212/WNL.0000000000207470.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Reader Response: Long-term Neurologic Safety in Patients With B-Cell Lymphoma Treated With Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy. Neurology 2023 May 3:10.1212/WNL.0000000000207470.
PMID: 37137726